Immunomodulation - hope for patient with Glioblastoma Multiforme
| Autor: | Jakub Litak; Joanna Litak; Wojciech Czyżewski; Paulina Miziak |
|---|---|
| Sprache: | Englisch; Spanisch; Polnisch; Russisch; Ukrainisch |
| Veröffentlicht: |
2018 |
| Quelle: | Directory of Open Access Journals: DOAJ Articles |
| Online Zugang: |
http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5940 https://doaj.org/toc/2391-8306 2391-8306 doi:10.5281/zenodo.1414230 https://doaj.org/article/bed9bfa30c1e4daaa650c8d708f37ab0 https://doi.org/10.5281/zenodo.1414230 https://doaj.org/article/bed9bfa30c1e4daaa650c8d708f37ab0 |
| Erfassungsnummer: | ftdoajarticles:oai:doaj.org/article:bed9bfa30c1e4daaa650c8d708f37ab0 |
Zusammenfassung
Glioblastoma multiforme is the most common and highly aggressive brain tumor, causing high number of death worldwide. Current therapies are not sufficient for patients. The surgical removal followed by radio- and chemotherapy became golden standard. Overall survival is still disappointing. New approach to GBM therapy is required . Immunotherapy seems to be a proper direction .